Can we predict severe reactions during peanut challenges in children?

Francine C van Erp1, André C Knulst, Petra A Kentie

  • 1Department of Paediatric Pulmonology and Allergology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands. f.c.vanerp@umcutrecht.nl

Insights

Predicting severe reactions during peanut oral food challenges is difficult. While factors like sIgE levels and male gender predict a positive challenge, they do not predict reaction severity, emphasizing the need for preparedness in all cases.

Area of Science:

  • Allergy and Immunology
  • Pediatric Allergy
  • Clinical Research

Background:

  • Limited data exists on risk factors for severe reactions during double-blind, placebo-controlled food challenges (DBPCFC).
  • Identifying predictors for severe reactions can improve safety and challenge setting selection.
  • This study focuses on children suspected of peanut allergy.

Purpose of the Study:

  • To identify predictors for positive and severe food challenge outcomes (FCO) in children undergoing peanut DBPCFC.
  • To determine if readily available patient data can predict reaction severity.
  • To enhance safety protocols for food allergy testing.

Main Methods:

  • Retrospective study of 225 children undergoing peanut DBPCFC over 3 years.
  • Reactions classified as mild/moderate (Sampson's grade 1-3) or severe (Sampson's grade 4-5).
  • Uni- and multivariable logistic regression used to identify predictors for positive and severe FCO.

Main Results:

  • 48% of children had a positive food challenge outcome (109/225).
  • 11% of children experienced a severe reaction (24/225).
  • Peanut sIgE levels, male gender, and co-existing food allergies were independent predictors of a positive FCO, but not severe reactions.

Conclusions:

  • Predictors for positive food challenge outcomes were identified.
  • No studied risk factors reliably predicted severe reactions during peanut challenges.
  • Clinicians must be prepared for severe reactions in all children undergoing peanut challenges, regardless of sensitization level.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Cross-reactivity00:42

Cross-reactivity

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...